Bluebrim Bioscience, an innovative bioanalysis CRO, provides analytical services for the quantitative measurement of drugs, biomarkers, and other substances in biological samples. We offer a comprehensive suite of services, including method development, method validation, sample analysis, and data reporting. We have employed advanced analytical techniques such as qPCR/ddPCR, ELSIA, ELISpot, LC-MS/MS, Flow cytometry, NGS, Cell-based assays, etc. to accurately quantify and characterize small and large molecules drugs in biological matrices like blood, urine, and tissues. By collaborating closely with pharmaceutical companies, biotech firms, and research institutions, Bluebrim bioscience has been making an earnest effort to the evaluation of drug safety, pharmacokinetics, efficacy, and biomarker helping to ensure regulatory compliance and accelerate the drug development process. Our expertise in bioanalytical sciences supports advancements in medical research and the development of new therapeutic interventions.